Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Weidinger

Showing results (111-120 of 274) with videos related to

Pageof 28
Sort By:
Dermatology and Therapy|March 16, 2023
Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey)Amy S Paller, Stephan Weidinger, Korey Capozza, et al.
Journal of Photochemistry and Photobiology. B, Biology|August 14, 2014
Influence of external, intrinsic and individual behaviour variables on serum 25(OH)D in a German surveyKatja Richter, Susanne Breitner, Ann R Webb, et al.
American Journal of Clinical Dermatology|July 20, 2022
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc AnalysisJonathan I Silverberg, David N Adam, Matthew Zirwas, et al.
The Journal of Allergy and Clinical Immunology|July 3, 2020
Atopic dermatitis displays stable and dynamic skin transcriptome signaturesLena Möbus, Elke Rodriguez, Inken Harder, et al.
The Journal of Allergy and Clinical Immunology|June 25, 2025
Collagen XXIII (COL23A1): A novel risk factor for eczema herpeticumShruti Chopra, Jana Zeitvogel, Stephan Traidl, et al.
Allergy|February 18, 2026
Integrated Methylome-Transcriptome Analysis Reveals Epigenomic Remodeling and Rho GTPase-Linked Immune-Epithelial Crosstalk in Atopic DermatitisTiina Skoog, Ying Yang, Peter Olah, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Stratum corneum and microbial biomarkers precede and characterize childhood atopic dermatitisMelina Fonfara, Jan Hartmann, Dora Stölzl, et al.
Dermatology and Therapy|October 21, 2022
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic DermatitisAmy S Paller, Gil Yosipovitch, Stephan Weidinger, et al.
The Journal of Dermatological Treatment|May 12, 2024
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trialsAdelaide A Hebert, Carsten Flohr, H Chih-Ho Hong, et al.
Acta Dermato-Venereologica|May 6, 2024
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibShawn G Kwatra, Marjolein De Bruin-Weller, Jonathan I Silverberg, et al.
Pageof 28

Showing results (111-120 of 274) with videos related to

Sort By:
Pageof 28
Dermatology and Therapy|March 16, 2023
Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey)Amy S Paller, Stephan Weidinger, Korey Capozza, et al.
Journal of Photochemistry and Photobiology. B, Biology|August 14, 2014
Influence of external, intrinsic and individual behaviour variables on serum 25(OH)D in a German surveyKatja Richter, Susanne Breitner, Ann R Webb, et al.
American Journal of Clinical Dermatology|July 20, 2022
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc AnalysisJonathan I Silverberg, David N Adam, Matthew Zirwas, et al.
The Journal of Allergy and Clinical Immunology|July 3, 2020
Atopic dermatitis displays stable and dynamic skin transcriptome signaturesLena Möbus, Elke Rodriguez, Inken Harder, et al.
The Journal of Allergy and Clinical Immunology|June 25, 2025
Collagen XXIII (COL23A1): A novel risk factor for eczema herpeticumShruti Chopra, Jana Zeitvogel, Stephan Traidl, et al.
Allergy|February 18, 2026
Integrated Methylome-Transcriptome Analysis Reveals Epigenomic Remodeling and Rho GTPase-Linked Immune-Epithelial Crosstalk in Atopic DermatitisTiina Skoog, Ying Yang, Peter Olah, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Stratum corneum and microbial biomarkers precede and characterize childhood atopic dermatitisMelina Fonfara, Jan Hartmann, Dora Stölzl, et al.
Dermatology and Therapy|October 21, 2022
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic DermatitisAmy S Paller, Gil Yosipovitch, Stephan Weidinger, et al.
The Journal of Dermatological Treatment|May 12, 2024
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trialsAdelaide A Hebert, Carsten Flohr, H Chih-Ho Hong, et al.
Acta Dermato-Venereologica|May 6, 2024
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibShawn G Kwatra, Marjolein De Bruin-Weller, Jonathan I Silverberg, et al.
Pageof 28